Serratus Posterior Superior Interfascial Plane Block for Thoracoscopic Surgery
Lung Diseases
About this trial
This is an interventional treatment trial for Lung Diseases focused on measuring VATS, Postoperative pain management, Serratus Posterior Superior Interfascial Plane Block
Eligibility Criteria
Inclusion Criteria: American Society of Anesthesiologists (ASA) classification I-III Scheduled for VATS under general anesthesia Exclusion Criteria: history of bleeding diathesis, receiving anticoagulant treatment, known local anesthetics and opioid allergy, infection of the skin at the site of the needle puncture, pregnancy or lactation, patients who do not accept the procedure
Sites / Locations
- Istanbul Medipol University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Other
Group S = SPSIPB group
Group C = Control group
A high-frequency linear US probe (11-12 MHz, Vivid Q) will be covered with a sterile sheath, and an 80 mm block needle (Braun 360°) will be used. The procedure will be performed with the patient in the lateral decubitus position. After the scapula is shifted slightly laterally, the US probe is placed sagittal at the upper corner of the spina scapula, and the serratus posterior superior muscle is visualized with the third rib. The in-plane technique will be used. The block needle will be advanced in the craniocaudal direction to enter between the serratus posterior superior and the third rib. The block location will be confirmed by injecting 5 ml of saline between the rib and the muscle. After the block location is confirmed, 30 ml of 0.25% concentration bupivacaine will be used.
The intercostal infiltration with 30 ml of 0.25% concentration of bupivacaine will be performed by the surgical team.